Characteristics associated with informed consent for genetic studies in the ACCORD trial.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Contemporary Clinical Trials

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cct.2013.12.002PMID 24355197PMCID PMC3918951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification, Evaluation, and Treatment of Overweight and Obesity

  2021cited by this paper
• Providing Contemporary Access to Historical Biospecimen Collections: Development of the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC)

  2015cited by this paper
• Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.

  2013cited by this paper
• Establish good genomic practice to guide medicine forward

  2013cited by this paper
• Personalized Genetic Risk Counseling to Motivate Diabetes Prevention

  2012cited by this paper
• Factors influencing patient willingness to participate in genetic research after a myocardial infarction

  2011cited by this paper
• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Has the revolution arrived?

  2010cited by this paper
• The path to personalized medicine.

  2010cited by this paper
• Effects of combination lipid therapy in type 2 diabetes mellitus.

  2010cited by this paper
• Ten years on--the human genome and medicine.

  2010cited by this paper
• Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities

  2010cited by this paper
• Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern.

  2010cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop

  2009cited by this paper
• Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.

  2007cited by this paper
• Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study

  2007cited by this paper
• Personalized medicine for high blood pressure.

  2007cited by this paper
• Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

  2007cited by this paper
• Obtaining informed consent for genetic studies: The multiethnic study of atherosclerosis.

  2006cited by this paper
• TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.

  2006cited by this paper
• Factors Associated with Enrollment in Cancer Genetics Research

  2006cited by this paper
• Consent for genetic research in a general population: The NHANES experience

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• The path to personalized medicine.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study

  2001cited by this paper
• Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.

  1998cited by this paper

• Genetic exceptionalism and genomic contextualism among Asian Americans: a qualitative study

  2025cites this paper
• Genetic counseling and testing for Asian Americans: a systematic review

  2021cites this paper
• Consent for participating in clinical trials - Is it really informed?

  2018cites this paper
• Consent for Genetic Biobanking in a Diverse Multisite CKD Cohort

  2018cites this paper
• Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response

  2016cites this paper